What's new — Anorexia nervosa¶
Generated 2026-09-03 from the publication dates of every paper cited in this condition's pages.
This page answers a different question from the curation log. The log says when we last edited a page; this says how recent the evidence on those pages is — so you can tell settled ground from a field that is actively moving, and jump straight to what has emerged lately.
How much of this condition's evidence is recent¶
| Published within | Cited papers |
|---|---|
| last week | 0 |
| last month | 1 |
| last 2 months | 2 |
| last 3 months | 4 |
| last 6 months | 10 |
| last year | 22 |
| older than a year | 260 |
Counts are cumulative: a paper from last week also counts inside "last month". Dates are PubMed publication or e-publication dates, so a paper may have appeared online before its journal issue.
Newest evidence first¶
The most recent cited papers, with the pages that use them.
| Published | Paper | Cited on |
|---|---|---|
| 2026-08-05 | An Invited Updated Systematic Review and Meta-Analysis Comparing Atypical Anorexia Nervosa and Anorexia Nervosa — Int J Eat Disord ([PMID 42557659](https://pubmed.ncbi.nlm.nih.gov/42557659/){target="_blank" rel="noopener"}) | diagnosis-and-classification, epidemiology-and-incidence, guidelines, medical-complications, mortality-and-long-term-outcome, overview, patient-experience-and-advocacy, red-flags-and-safety-concerns |
| 2026-07-06 | Stakeholder views on the proposed criteria for 'terminal anorexia': a mixed-methods study — Eat Disord ([PMID 42410953](https://pubmed.ncbi.nlm.nih.gov/42410953/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy, severe-enduring-illness-and-compulsory-treatment |
| 2026-07-01 | Theta burst stimulation of extrastriate body area for body perception in anorexia nervosa: a randomized controlled trial — Transl Psychiatry ([PMID 42386712](https://pubmed.ncbi.nlm.nih.gov/42386712/){target="_blank" rel="noopener"}) | neuromodulation-and-experimental-therapy |
| 2026-07-01 | Excess Mortality Among Patients With Anorexia Nervosa Treated Involuntarily — Int J Eat Disord ([PMID 42383339](https://pubmed.ncbi.nlm.nih.gov/42383339/){target="_blank" rel="noopener"}) | clinical-trials-landscape, guidelines, mortality-and-long-term-outcome, red-flags-and-safety-concerns, severe-enduring-illness-and-compulsory-treatment |
| 2026-06-01 | What are the arguments for and against recognizing 'terminal' anorexia nervosa? A narrative review — Int Rev Psychiatry ([PMID 42312722](https://pubmed.ncbi.nlm.nih.gov/42312722/){target="_blank" rel="noopener"}) | severe-enduring-illness-and-compulsory-treatment |
| 2026-06-01 | Efficacy and safety of repetitive transcranial magnetic stimulation in anorexia and bulimia nervosa: a systematic review and meta-analysis — Ann Gen Psychiatry ([PMID 42226264](https://pubmed.ncbi.nlm.nih.gov/42226264/){target="_blank" rel="noopener"}) | neuromodulation-and-experimental-therapy |
| 2026-05-02 | Investigating Relationships Between Genetic Risk, Childhood Maltreatment, and Eating Disorders in Women — Biol Psychiatry Glob Open Sci ([PMID 42471970](https://pubmed.ncbi.nlm.nih.gov/42471970/){target="_blank" rel="noopener"}) | genetics |
| 2026-05-01 | Olanzapine for young people with anorexia nervosa: a synopsis of the main results from the OPEN open-label feasibility study — Health Technol Assess ([PMID 42116676](https://pubmed.ncbi.nlm.nih.gov/42116676/){target="_blank" rel="noopener"}) | clinical-trials-landscape, pharmacotherapy |
| 2026-04-03 | Integrative GWAS identifies novel loci and genetic links between psychiatric and metabolic factors in anorexia nervosa — Mol Psychiatry ([PMID 41927769](https://pubmed.ncbi.nlm.nih.gov/41927769/){target="_blank" rel="noopener"}) | genetics |
| 2026-04-02 | Protocol for a pilot feasibility randomised controlled trial of fecal microbiota transplantation for adolescent anorexia nervosa — BMJ Open ([PMID 42009386](https://pubmed.ncbi.nlm.nih.gov/42009386/){target="_blank" rel="noopener"}) | genetics |
| 2026-02-01 | Medication use in severe anorexia nervosa: a Danish register-based study — BMJ Ment Health ([PMID 41688100](https://pubmed.ncbi.nlm.nih.gov/41688100/){target="_blank" rel="noopener"}) | pharmacotherapy |
| 2026-02-01 | All-cause and cause-specific mortality risk in individuals with eating disorders: systematic review and meta-analysis of relative risk and aggravating or attenuating factors — World Psychiatry ([PMID 41536100](https://pubmed.ncbi.nlm.nih.gov/41536100/){target="_blank" rel="noopener"}) | mortality-and-long-term-outcome, overview, red-flags-and-safety-concerns |
| 2026-01-02 | Effects of teriparatide on hip structure and bone microarchitecture in women with anorexia nervosa: a placebo-controlled randomized trial — Osteoporos Int ([PMID 41591404](https://pubmed.ncbi.nlm.nih.gov/41591404/){target="_blank" rel="noopener"}) | medical-complications |
| 2026-01-02 | Clinicians' Experiences With Providing Compulsory Nasogastric Tube Feeding: A Commentary on Offringa et al. (2025) — Int J Eat Disord ([PMID 41481023](https://pubmed.ncbi.nlm.nih.gov/41481023/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2026-01-01 | Impact of a single fecal microbiome transplantation in adult women with anorexia nervosa: an open-label feasibility pilot trial — Nat Commun ([PMID 41535289](https://pubmed.ncbi.nlm.nih.gov/41535289/){target="_blank" rel="noopener"}) | genetics |
| 2025-11-03 | Clinicians' Experiences of Providing Compulsory Care for Youth With Anorexia Nervosa: A Qualitative Study — Int J Eat Disord ([PMID 41185403](https://pubmed.ncbi.nlm.nih.gov/41185403/){target="_blank" rel="noopener"}) | patient-experience-and-advocacy |
| 2025-11-02 | Systematic Review and Meta-Analysis of Mortality in Patients With Anorexia Nervosa — Int J Eat Disord ([PMID 41277145](https://pubmed.ncbi.nlm.nih.gov/41277145/){target="_blank" rel="noopener"}) | mortality-and-long-term-outcome, overview, red-flags-and-safety-concerns |
| 2025-11-01 | Anorexia nervosa symptoms are induced after specific gut microbiota dysbiosis transfer in germ-free mice — Gut Microbes ([PMID 41239983](https://pubmed.ncbi.nlm.nih.gov/41239983/){target="_blank" rel="noopener"}) | genetics |
| 2025-11-01 | Intensive community and home-based treatments for eating disorders: a scoping review — J Eat Disord ([PMID 41214774](https://pubmed.ncbi.nlm.nih.gov/41214774/){target="_blank" rel="noopener"}) | service-models-and-setting |
| 2025-10-02 | Maladaptive Exercise in People With a Lifetime History of Eating Disorders: A Multicountry Observational Study — Int J Eat Disord ([PMID 41115789](https://pubmed.ncbi.nlm.nih.gov/41115789/){target="_blank" rel="noopener"}) | red-flags-and-safety-concerns |
| 2025-10-01 | Anorexia nervosa and risk of fractures: A matched cohort study of 80,000 men and women — Am J Med ([PMID 41109616](https://pubmed.ncbi.nlm.nih.gov/41109616/){target="_blank" rel="noopener"}) | guidelines, medical-complications |
| 2025-09-03 | Fluoxetine for anorexia nervosa after weight restoration: moderation of effect by depression — Psychol Med ([PMID 41022691](https://pubmed.ncbi.nlm.nih.gov/41022691/){target="_blank" rel="noopener"}) | pharmacotherapy |
Trials — what has moved¶
46 registered trials are cited by this condition's pages. Registry records were re-checked live when this page was generated, so status, enrolment and results-posting below reflect ClinicalTrials.gov as of that date.
| Registry activity | Trials |
|---|---|
| trial records updated in the last week | 0 |
| trial records updated in the last month | 4 |
| trial records updated in the last 2 months | 7 |
| trial records updated in the last 3 months | 8 |
| trial records updated in the last 6 months | 12 |
| trial records updated in the last year | 24 |
Recently updated registrations¶
Posted efficacy and safety results¶
Trials whose sponsors have posted results to the registry. Adverse-event figures are participant counts summed across all arms as reported — read them against enrolment, and follow the registry link for the arm-by-arm breakdown that determines whether a signal is real.
| Results posted | Trial | Phase | N | Primary outcome | Serious AE | Other AE | Deaths |
|---|---|---|---|---|---|---|---|
| 2021-06-24 | Study of Refeeding to Optimize iNpatient Gains | NA | 120 | Number of Participants With Clinical Remission at Different Time Point | 24 | 35 | 0 |
| 2016-07-11 | Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Wo | PHASE4 | 93 | Proportion of Patients Remaining in Study at 1 Year | 1 | 0 | 0 |
| 2016-02-02 | A Double-blind, Placebo Controlled Trial of Risperidone for the Treatm | PHASE4 | 41 | Change in Eating Disorder Inventory-2 Drive for Thinness Subscale (DT) | 0 | 33 | 0 |
31 of these trials are still recruiting or active — see the condition's clinical trials page for the full landscape.
Which pages rest on the newest evidence¶
🔥 marks a page citing three or more papers from the last year — the pages worth re-reading if you have been away.
| Page | Newest citation | In last year | Total citations |
|---|---|---|---|
| diagnosis-and-classification | 2026-08-05 | 1 | 18 |
| epidemiology-and-incidence | 2026-08-05 | 1 | 20 |
| guidelines | 2026-08-05 | 3 | 21 |
| medical-complications | 2026-08-05 | 3 | 25 |
| mortality-and-long-term-outcome | 2026-08-05 | 4 | 20 |
| overview | 2026-08-05 | 3 | 28 |
| patient-experience-and-advocacy | 2026-08-05 | 4 | 25 |
| red-flags-and-safety-concerns | 2026-08-05 | 5 | 20 |
| severe-enduring-illness-and-compulsory-treatment | 2026-07-06 | 3 | 26 |
| clinical-trials-landscape | 2026-07-01 | 2 | 20 |
| neuromodulation-and-experimental-therapy | 2026-07-01 | 2 | 25 |
| genetics | 2026-05-02 | 5 | 30 |
| pharmacotherapy | 2026-05-01 | 3 | 21 |
| service-models-and-setting | 2025-11-01 | 1 | 21 |
| refeeding-and-nutritional-rehabilitation | 2025-02-01 | 0 | 19 |
| treatment-in-adults | 2025-02-01 | 0 | 18 |
| treatment-in-adolescents | 2025-01-07 | 0 | 19 |
| neurobiology-and-cognition | 2024-11-01 | 0 | 31 |
Recency is not quality: an old paper may be the definitive one, and a new paper may not replicate. Use this to find movement, not to rank evidence. See open questions for what remains unresolved, and the curation log for when these pages were last revised.